Pamella J. Ford

1.3k total citations
19 papers, 892 citations indexed

About

Pamella J. Ford is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, Pamella J. Ford has authored 19 papers receiving a total of 892 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 5 papers in Hematology and 5 papers in Immunology. Recurrent topics in Pamella J. Ford's work include Polyamine Metabolism and Applications (5 papers), Complement system in diseases (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Pamella J. Ford is often cited by papers focused on Polyamine Metabolism and Applications (5 papers), Complement system in diseases (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Pamella J. Ford collaborates with scholars based in United States, Russia and United Kingdom. Pamella J. Ford's co-authors include Ursula A. Germann, Savvas C. Makrides, Mark Namchuk, Matthew W. Harding, Valerie S. Mason, Caroline J. Decker, George Ku, Paul S. Charifson, John C.R. Randle and John R. Pollard and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Pamella J. Ford

19 papers receiving 871 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pamella J. Ford United States 11 557 221 164 95 90 19 892
Julia M. Ayala United States 18 464 0.8× 440 2.0× 278 1.7× 63 0.7× 72 0.8× 22 1.1k
Harald Dinter United States 17 590 1.1× 276 1.2× 233 1.4× 40 0.4× 75 0.8× 22 1.1k
Carol Homon United States 12 836 1.5× 176 0.8× 148 0.9× 29 0.3× 64 0.7× 21 1.2k
S. Barker United States 12 557 1.0× 300 1.4× 121 0.7× 70 0.7× 191 2.1× 18 1.3k
Brian Bolognese United States 18 522 0.9× 380 1.7× 265 1.6× 42 0.4× 48 0.5× 34 1.2k
Janey N. Parsons United States 9 384 0.7× 179 0.8× 126 0.8× 48 0.5× 28 0.3× 10 691
Hollis R. Williams United States 12 337 0.6× 146 0.7× 155 0.9× 46 0.5× 30 0.3× 15 810
Annette Schwartz United States 12 297 0.5× 259 1.2× 199 1.2× 261 2.7× 69 0.8× 17 918
Vivek J. Kadambi United States 21 1.1k 1.9× 168 0.8× 145 0.9× 55 0.6× 91 1.0× 41 1.7k
Julia K. Archbold Australia 15 324 0.6× 616 2.8× 135 0.8× 119 1.3× 116 1.3× 21 1.1k

Countries citing papers authored by Pamella J. Ford

Since Specialization
Citations

This map shows the geographic impact of Pamella J. Ford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pamella J. Ford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pamella J. Ford more than expected).

Fields of papers citing papers by Pamella J. Ford

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pamella J. Ford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pamella J. Ford. The network helps show where Pamella J. Ford may publish in the future.

Co-authorship network of co-authors of Pamella J. Ford

This figure shows the co-authorship network connecting the top 25 collaborators of Pamella J. Ford. A scholar is included among the top collaborators of Pamella J. Ford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pamella J. Ford. Pamella J. Ford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Tang, Qing, Alex M. Aronov, David D. Deininger, et al.. (2021). Discovery of Potent, Selective Triazolothiadiazole-Containing c-Met Inhibitors. ACS Medicinal Chemistry Letters. 12(6). 955–960. 12 indexed citations
2.
Boucher, Diane M., Russell R. Hoover, Yuxin Wang, et al.. (2016). Abstract 3716: Potent radiation enhancement with VX-984, a selective DNA-PKcs inhibitor for the treatment of NSCLC. Cancer Research. 76(14_Supplement). 3716–3716. 5 indexed citations
3.
4.
Aronov, Alex M., Christopher Baker, Guy W. Bemis, et al.. (2007). Flipped Out:  Structure-Guided Design of Selective Pyrazolylpyrrole ERK Inhibitors. Journal of Medicinal Chemistry. 50(6). 1280–1287. 98 indexed citations
5.
Jain, Jugnu, Randall Hoover, Pamella J. Ford, et al.. (2004). 488 VX-944: an inosine monophosphate dehydrogenase inhibitor with unique anti-cancer activity. European Journal of Cancer Supplements. 2(8). 149–149. 3 indexed citations
6.
Jain, Jugnu, Susan J. Almquist, Pamella J. Ford, et al.. (2003). Regulation of inosine monophosphate dehydrogenase type I and type II isoforms in human lymphocytes. Biochemical Pharmacology. 67(4). 767–776. 69 indexed citations
7.
Fox, Ted, Joyce T. Coll, Xiaoling Xie, et al.. (1998). A single amino acid substitution makes ERK2 susceptible to pyridinyl imidazole inhibitors of p38 MAP kinase. Protein Science. 7(11). 2249–2255. 115 indexed citations
8.
9.
Scesney, Susanne M., Savvas C. Makrides, Michael Gosselin, et al.. (1996). A soluble deletion mutant of the human complement receptor type 1, which lacks the C4b binding site, is a selective inhibitor of the alternative complement pathway. European Journal of Immunology. 26(8). 1729–1735. 28 indexed citations
10.
Makrides, Savvas C., Per‐Åke Nygren, Pamella J. Ford, et al.. (1996). Extended in vivo half-life of human soluble complement receptor type 1 fused to a serum albumin-binding receptor.. Journal of Pharmacology and Experimental Therapeutics. 277(1). 534–542. 73 indexed citations
11.
Andrews, Beth, Hedy Adari, Gerhard Hannig, et al.. (1996). A tightly regulated high level expression vector that utilizes a thermosensitive lac repressor: production of the human T cell receptor Vβ5.3 in Escherichia coli. Gene. 182(1-2). 101–109. 20 indexed citations
12.
Adari, Hedy, Beth Andrews, Pamella J. Ford, et al.. (1995). Expression of the Human T-Cell Receptor Vβ5.3 in Escherichia coli by Thermal Induction of the trc Promoter: Nucleotide Sequence of the lacIts Gene. DNA and Cell Biology. 14(11). 945–950. 7 indexed citations
13.
Makrides, Savvas C., et al.. (1994). Quantitative analysis of C4b dimer binding to distinct sites on the C3b/C4b receptor (CR1).. Journal of Biological Chemistry. 269(10). 7696–7701. 28 indexed citations
14.
Makrides, Savvas C., Susanne M. Scesney, Pamella J. Ford, et al.. (1992). Cell surface expression of the C3b/C4b receptor (CR1) protects Chinese hamster ovary cells from lysis by human complement.. Journal of Biological Chemistry. 267(34). 24754–24761. 44 indexed citations
15.
Barranco, S. C., et al.. (1990). Schedule dependent potentiation of antitumor drug effects by α-difluoromethylornithine in human gastric carcinoma cells in vitro. Investigational New Drugs. 8(S1). S9–S18. 3 indexed citations
16.
Arnold, Janosch, Pamella J. Ford, Norma H. Rubin, et al.. (1989). Twenty-Four-Hour Variations in Ornithine Decarboxylase and Acid Phosphatase in Mice. Experimental Biology and Medicine. 191(4). 420–424. 6 indexed citations
17.
Barranco, S. C., Pamella J. Ford, & C. M. Townsend. (1989). Heterogeneous survival and cell kinetics responses of human astrocytoma clones to α-difluoromethylornithine in vitro. Investigational New Drugs. 7(2-3). 155–161. 3 indexed citations
18.
Barranco, S. C., Pamella J. Ford, & C. M. Townsend. (1986). Cell cycle kinetics responses of human stomach cancer cells to reduction in polyamine levels by treatment with αDifluoromethylornithine in vitro. Investigational New Drugs. 4(4). 347–357. 5 indexed citations
19.
Barranco, S. C., Pamella J. Ford, & C. M. Townsend. (1986). Heterogeneous survival responses of human gastric cancer clones to αDifluoromethylornithine in vitro. Investigational New Drugs. 4(4). 337–345. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julia M. Ayala Breakdown of academic impact, for papers by Harald Dinter Breakdown of academic impact, for papers by Carol Homon Breakdown of academic impact, for papers by S. Barker Breakdown of academic impact, for papers by Brian Bolognese Breakdown of academic impact, for papers by Janey N. Parsons Breakdown of academic impact, for papers by Hollis R. Williams Breakdown of academic impact, for papers by Annette Schwartz Breakdown of academic impact, for papers by Vivek J. Kadambi Breakdown of academic impact, for papers by Julia K. Archbold
Rankless by CCL
2026